Access and Barriers to Take-Home Naloxone Use among Emergency Department Patients with Opioid Misuse in Baltimore, Maryland, USA

References

• Ashrafioun, L., Gamble, S., Herrmann, M., & Baciewicz, G. (2016). Evaluation of knowledge and confidence following opioid overdose prevention training: A comparison of types of training participants and naloxone administration methods. Substance Abuse, 37(1), 76–81. https://doi.org/10.1080/08897077.2015.1110550
   PubMed Web of Science ®Google Scholar
• Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014). A systematic review of community opioid overdose prevention and naloxone distribution programs. Journal of Addiction Medicine, 8(3), 153–163.
   PubMed Web of Science ®Google Scholar
• Dietze, P. M., Stare, M., Cogger, S., Nambiar, D., Olsen, A., Burns, L., & Lenton, S. (2018). Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital cities. Drug and Alcohol Review, 37(4), 457–463. https://doi.org/10.1111/dar.12644
   PubMed Web of Science ®Google Scholar
• Doe-Simkins, M., Quinn, E., Xuan, Z., Sorensen-Alawad, A., Hackman, H., Ozonoff, A., & Walley, A. Y. (2014). Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: A retrospective cohort study. BMC Public Health, 14, 297. https://doi.org/10.1186/1471-2458-14-297
   PubMed Web of Science ®Google Scholar
• D'Onofrio, G., McCormack, R. P., & Hawk, K. (2018). Emergency departments - A 24/7/365 option for combating the opioid crisis. The New England Journal of Medicine, 379(26), 2487–2490. https://doi.org/10.1056/NEJMp1811988
   PubMed Web of Science ®Google Scholar
• Evoy, K. E., Hill, L. G., Groff, L., Mazin, L., Carlson, C. C., & Reveles, K. R. (2018). Naloxone accessibility without a prescriber encounter under standing orders at community pharmacy chains in Texas. JAMA, 320(18), 1934–1937. https://doi.org/10.1001/jama.2018.15892
   PubMed Web of Science ®Google Scholar
• Follman, S., Arora, V. M., Lyttle, C., Moore, P. Q., & Pho, M. T. (2019). Naloxone prescriptions among commercially insured individuals at high risk of opioid overdose. JAMA Network Open, 2(5), e193209. https://doi.org/10.1001/jamanetworkopen.2019.3209
   PubMed Web of Science ®Google Scholar
• Freeman, P. R., Hankosky, E. R., Lofwall, M. R., & Talbert, J. C. (2018). The changing landscape of naloxone availability in the United States, 2011 - 2017. Drug and Alcohol Dependence, 191, 361–364. https://doi.org/10.1016/j.drugalcdep.2018.07.017
   PubMed Web of Science ®Google Scholar
• Giglio, R. E., Li, G., & DiMaggio, C. J. (2015). Effectiveness of bystander naloxone administration and overdose education programs: A meta-analysis. Injury Epidemiology, 2(1), 10–19. https://doi.org/10.1186/s40621-015-0041-8
   PubMedGoogle Scholar
• Goldman-Hasbun, J., DeBeck, K., Buxton, J. A., Nosova, E., Wood, E., & Kerr, T. (2017). Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: A cohort study. Harm Reduction Journal, 14(1), 79. https://doi.org/10.1186/s12954-017-0206-6
   PubMed Web of Science ®Google Scholar
• Guadamuz, J. S., Alexander, G. C., Chaudhri, T., Trotzky-Sirr, R., & Qato, D. M. (2019). Availability and cost of naloxone nasal spray at pharmacies in Philadelphia, Pennsylvania, 2017. JAMA Network Open, 2(6), e195388. https://doi.org/10.1001/jamanetworkopen.2019.5388
   PubMed Web of Science ®Google Scholar
• Gunn, A. H., Smothers, Z. P. W., Schramm-Sapyta, N., Freiermuth, C. E., MacEachern, M., & Muzyk, A. J. (2018). The emergency department as an opportunity for naloxone distribution. The Western Journal of Emergency Medicine, 19 (6), 1036–1042. https://doi.org/10.5811/westjem.2018.8.38829
   PubMed Web of Science ®Google Scholar
• Kestler, A., Buxton, J., Meckling, G., GIesler, A., Lee, M., Fuller, K., Quian, H., Marks, D., & Scheuermeyer, F. (2017). Factors associated with participation in an emergency department-based take-home naloxone program for at-risk opioid users. Annals of Emergency Medicine, 69(3), 340–346. https://doi.org/10.1016/j.annemergmed.2016.07.027
   PubMed Web of Science ®Google Scholar
• Lambdin, B. H., Zibbell, J., Wheeler, E., & Kral, A. H. (2018). Identifying gaps in the implementation of naloxone programs for laypersons in the United States. The International Journal on Drug Policy, 52, 52–55. https://doi.org/10.1016/j.drugpo.2017.11.017
   PubMed Web of Science ®Google Scholar
• Lozo, K. W., Nelson, L. S., Ramdin, C., & Calello, D. P. (2019). Naloxone deserts in NJ cities: Sociodemographic factors which may impact retail pharmacy naloxone availability. Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology, 15(2), 108–111. https://doi.org/10.1007/s13181-019-00700-7
   PubMed Web of Science ®Google Scholar
• McAuley, A., Munro, A., Bird, S. M., Hutchinson, S. J., Goldberg, D. J., & Taylor, A. (2016). Engagement in a National Naloxone Programme among people who inject drugs. Drug and Alcohol Dependence, 162, 236–240. https://doi.org/10.1016/j.drugalcdep.2016.02.031
   PubMed Web of Science ®Google Scholar
• Murphy, S. L., Xu, J. Q., Kochanek, K. D., Arias, E. (2018). Mortality in the United States, 2017. NCHS Data Brief, (328). https://www.cdc.gov/nchs/products/databriefs/db328.htm
   Google Scholar
• National Institute on Drug Abuse (NIDA). (2019, January). Overdose death rates. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates.
   Google Scholar
• Nolan, S., Buxton, J., Dobrer, S., Dong, H., Hayashi, K., Milloy, M. J., Kerr, T., Montaner, J., & Wood, E. (2017). Awareness, possession, and use of take-home naloxone among illicit drug users, Vancouver, British Columbia, 2014-2015. Public Health Reports, 132(5), 563–569. https://doi.org/10.1177/0033354917717230
   PubMed Web of Science ®Google Scholar
• O'Brien, D. C., Dabbs, D., Dong, K., Veugelers, P. J., & Hyshka, E. (2019). Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: A retrospective chart review. BMC Health Services Research, 19(1), 632. https://doi.org/10.1186/s12913-019-4469-3
   PubMed Web of Science ®Google Scholar
• Puzantian, T., & Gasper, J. J. (2018). Provision of naloxone without a prescription by California pharmacists 2 years after legislation implementation. JAMA, 320(18), 1933–1934. https://doi.org/10.1001/jama.2018.12291
   PubMed Web of Science ®Google Scholar
• Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2018). Drug and opioid-involved overdose Deaths - United States, 2013–2017. Morbidity and Mortality Weekly Report, 67(5152), 1419–1427. https://doi.org/10.15585/mmwr.mm675152e1
   PubMedGoogle Scholar
• Wheeler, E., Jones, T. S., Gilbert, M. K., & Davidson, P. J. (2015). Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. MMWR. Morbidity and Mortality Weekly Report, 64(23), 631–635.
   PubMed Web of Science ®Google Scholar
• Williams, A. V., Marsden, J., & Strang, J. (2014). Training family members to manage heroin overdose and administer naloxone: Randomized trial of effects on knowledge and attitudes. Addiction, 109(2), 250–259. https://doi.org/10.1111/add.12360
   PubMed Web of Science ®Google Scholar